117 related articles for article (PubMed ID: 9407003)
1. Sequence variations between two Epstein-Barr virus LMP 1 variants have no effect on the activation of NF-kappaB activity.
Yeh TS; Li SN; Wu CJ; Liu ST; Meng CL; Chang YS
DNA Cell Biol; 1997 Nov; 16(11):1311-9. PubMed ID: 9407003
[TBL] [Abstract][Full Text] [Related]
2. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
Miller WE; Edwards RH; Walling DM; Raab-Traub N
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
[TBL] [Abstract][Full Text] [Related]
3. The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain.
Coffin WF; Erickson KD; Hoedt-Miller M; Martin JM
Oncogene; 2001 Aug; 20(38):5313-30. PubMed ID: 11536044
[TBL] [Abstract][Full Text] [Related]
4. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
[TBL] [Abstract][Full Text] [Related]
5. Identification of an internal promoter of the latent membrane protein 1 gene of Epstein-Barr virus.
Chen ML; Hsu NC; Liu ST; Chang YS
DNA Cell Biol; 1995 Mar; 14(3):205-11. PubMed ID: 7880441
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.
Chen ML; Tsai CN; Liang CL; Shu CH; Huang CR; Sulitzeanu D; Liu ST; Chang YS
Oncogene; 1992 Nov; 7(11):2131-40. PubMed ID: 1331932
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.
Mitchell T; Sugden B
J Virol; 1995 May; 69(5):2968-76. PubMed ID: 7707523
[TBL] [Abstract][Full Text] [Related]
8. Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling.
Shimabuku T; Tamanaha A; Kitamura B; Tanabe Y; Tawata N; Ikehara F; Arakaki K; Kinjo T
Int J Clin Exp Pathol; 2014; 7(5):1920-34. PubMed ID: 24966902
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes.
Sample J; Kieff EF; Kieff ED
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2741-6. PubMed ID: 7931160
[TBL] [Abstract][Full Text] [Related]
10. The cytoplasmic C-terminal domain but not the N-terminal domain of latent membrane protein 1 of Epstein-Barr virus is essential for B cell activation.
Peng-Pilon M; Ruuth K; Lundgren E; Brodin P
J Gen Virol; 1995 Apr; 76 ( Pt 4)():767-77. PubMed ID: 9049322
[TBL] [Abstract][Full Text] [Related]
11. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
[TBL] [Abstract][Full Text] [Related]
12. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma].
Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H
Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006
[TBL] [Abstract][Full Text] [Related]
13. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus.
Li SN; Chang YS; Liu ST
Oncogene; 1996 May; 12(10):2129-35. PubMed ID: 8668338
[TBL] [Abstract][Full Text] [Related]
14. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
[TBL] [Abstract][Full Text] [Related]
15. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.
Yoshizaki T; Horikawa T; Qing-Chun R; Wakisaka N; Takeshita H; Sheen TS; Lee SY; Sato H; Furukawa M
Clin Cancer Res; 2001 Jul; 7(7):1946-51. PubMed ID: 11448908
[TBL] [Abstract][Full Text] [Related]
16. Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs.
Brodeur SR; Cheng G; Baltimore D; Thorley-Lawson DA
J Biol Chem; 1997 Aug; 272(32):19777-84. PubMed ID: 9242637
[TBL] [Abstract][Full Text] [Related]
17. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene.
Busson P; Edwards RH; Tursz T; Raab-Traub N
J Gen Virol; 1995 Jan; 76 ( Pt 1)():139-45. PubMed ID: 7844523
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-κB.
Ishikawa C; Mori N
Int J Oncol; 2013 May; 42(5):1786-92. PubMed ID: 23546309
[TBL] [Abstract][Full Text] [Related]
19. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2.
Martin JM; Veis D; Korsmeyer SJ; Sugden B
J Virol; 1993 Sep; 67(9):5269-78. PubMed ID: 8394449
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
Takeshita H; Yoshizaki T; Miller WE; Sato H; Furukawa M; Pagano JS; Raab-Traub N
J Virol; 1999 Jul; 73(7):5548-55. PubMed ID: 10364303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
